Filters
![]() |
|
| |||
1246 of 1296 products, sorted A-Z
|
2.5 ★★ (6)★ ☆ ☆☆ |
Doja |
THC | 200 - 280mg/g (24%) | THC MEDIUM | 0 - 1mg/g (0.0%) | CBD |
eweed.pro | SATIVA | csmeter © |
$12.21* ![]() |
1.5g | $8.14/g |
![]() |
Citrus 2/10 |
AROMA / FLVR |
|
+Herbal 1 |
+Spice 1 |
![]() |
Anxiety 2/10 |
AID** WITH |
|
+Energy 2 |
+Focus 1 |
Potency | THC Medium | |
THC | 200-280mg/g | 24% |
CBD | 0-1mg/g | 0.0% |
Plant | Sativa Dominant | |
Grown In | Quebec | |
Method | INDOOR | |
Producer | Doja by Canopy Growth Corp. | |
GTIN# |
00688083011078 (1.5g) |
Masterfully pre-rolled joints containing Doja Ultra Sour, a high THC, sativa-dominant strain. Doja Ultra Sour is bred from OG strains East Coast Sour Diesel and MK Ultra. Together this lineage creates a strain that emits a pungent citrus aroma and flavour profile. Ultra Sour's pungent aroma is complemented by its unique buds covered in trichomes and lots of dark orange pistils.
Doja was born amid the natural beauty and abundance of British Columbia’s Okanagan Valley, with rebellious spirit and a love for the land. Perfecting the craft of cannabis cultivation is our passion, from genetics to curing to trimming. We produce only premium flower, uncompromising on the small stuff that makes a big difference.
With heritage standards and innovative plant science, we aspire to make each batch better than the one that came before it.
About Canopy Growth
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.
2.0 ★★ ☆☆☆ |
Arkadi | May-23 |
1.0 ★ ☆☆☆☆ |
Kathy | Oct-22 |
1.0 ★ ☆☆☆☆ |
Marty | Jun-22 |
1.0 ★ ☆☆☆☆ |
Daniel | Apr-22 |
5.0 ★★★★★ |
Richard | Feb-22 |